S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Pazopanib and temsirolimus may stop the growth of tumor cells by blocking some of
the enzymes needed for cell growth. Pazopanib may also blocking blood flow to the tumor.
Giving pazopanib together with temsirolimus may be an effective treatment for advanced solid
tumors.
PURPOSE: This phase I trial is studying the side effects and best dose of temsirolimus when
given together with pazopanib in treating patients with advanced solid tumors.